By Anne Trias, MS, American River Nutrition03.02.22
Cardiometabolic syndrome, recognized as a disease entity by the World Health Organization, is a complex combination of metabolic and cardiovascular dysfunctions.1,2 Among lifestyle changes such as revamped diets and exercise schedules, dietary supplements provide adjunctive relief for many of the risk factors associated with the syndrome.
Vitamin E—known as a universal antioxidant—has been trialed variously in support of cardiometabolic health, often with conflicting and disappointing results.3 Without regard to its isomeric diversity, many have turned their back on vitamin E and its potential benefits for heart and metabolic health. Emerging clinical research, however, suggests tocotrienols to be far superior to their tocopherol cousins in providing cardiometabolic relief.
Vitamin E Unriddled
Everyone is familiar with vitamin E, but few are aware that the term encompasses an entire family of distinct, albeit related, compounds. Vitamin E in the form of alpha-tocopherol celebrates its 100th birthday in 2022, marking its discovery as an essential component to fetal development
Vitamin E—known as a universal antioxidant—has been trialed variously in support of cardiometabolic health, often with conflicting and disappointing results.3 Without regard to its isomeric diversity, many have turned their back on vitamin E and its potential benefits for heart and metabolic health. Emerging clinical research, however, suggests tocotrienols to be far superior to their tocopherol cousins in providing cardiometabolic relief.
Vitamin E Unriddled
Everyone is familiar with vitamin E, but few are aware that the term encompasses an entire family of distinct, albeit related, compounds. Vitamin E in the form of alpha-tocopherol celebrates its 100th birthday in 2022, marking its discovery as an essential component to fetal development
Continue reading this story and get 24/7 access to Nutraceuticals World for FREE
FREE SUBSCRIPTION
